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OBJECTIVEdTo establish minimal clinically important difference (MCID) scores represent-
ing the smallest detectable change in quality of life (QOL), using the Pediatric Quality of Life
Inventory (PedsQL) Generic Core and Diabetes Module among youth with diabetes and their
parents, and to identify demographic and clinical correlates of QOL change over 1 year.
RESEARCH DESIGN AND METHODSdParticipants in the SEARCH for Diabetes in
Youth Study aged.5 years and parents of youth aged,18 years completed PedsQL surveys at
their initial and 12-month study visits. MCIDs for each PedsQL module were calculated using
one standard error of measurement. Demographic and clinical characteristics associated with
QOL change were identified through multiple linear and logistic regression analyses.
RESULTSdThe sample comprised 5,004 youth (mean age, 12.5 6 4.7 years; mean diabetes
duration, 3.46 3.7 years). Of 100 possible points, PedsQL total score MCIDs for youth with type 1
and type 2 diabetes, respectively, were Generic Core, 4.88, 6.27 (parent) and 4.72, 5.41 (youth);
Diabetes Module, 4.54, 6.06 (parent) and 5.27, 5.96 (youth). Among 1,402 youth with a follow-up
visit, lower baseline QOL, male sex, private insurance, having type 1 diabetes, longer diabetes
duration, and better glycemic control predicted improvements in youth- and parent-reported
PedsQL total scores over 1 year. Clinically meaningful ($1 MCID) improvements in total score
for at least one PedsQL module were predicted by private insurance, lower BMI, and lower A1C at
baseline.
CONCLUSIONSdThesediabetes-specific referencepoints to interpret clinicallymeaningful change
in PedsQL scores can be used in clinical care and research for youth with type 1 and type 2 diabetes.
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Quality of life (QOL) is an importanthealth outcome representing subjec-tive well-being in domains directly
and indirectly related to a chronic illness
and its management (1,2), including phys-
ical symptoms, disease management and
barriers, disease-relatedworries, and social,
academic, and emotional functioning (3).
Clinical trials research frequently uses QOL
as a clinically relevant patient-reported
outcome (PRO) (2,4). In pediatric diabe-
tes, the importance of QOL and its asso-
ciations with diabetes management and
control have gained increasing attention
(5). Impairments in general and health-
related QOL have demonstrated links
with suboptimal outcomes, including
poor glycemic control (6–10).
Clinicians in pediatric diabetes clinics
may observe fluctuations in their patients’
mood, behavior, and QOL and may be
concerned how these fluctuations will af-
fect their patients’ overall health and well-
being. Likewise, clinical trials researchers
who measure QOL as a key PRO must
speculate about the degree to which ob-
served changes in participants’ scores are
meaningful in interpreting their trial re-
sults. Unlike other screening instruments
(e.g., for depression), QOL assessments
do not have clinical cutoffs indicating
clinically meaningful values. As such,
there is a need for a reference point for
clinicians and researchers to interpret
the clinical significance of changes in
youths’ QOL over time.
The Pediatric Quality of Life Inven-
tory (PedsQL) is a commonly used, psy-
chometrically sound measure of general
(Generic Core) and diabetes-specific (Di-
abetes Module) health-related QOL (3).
The content of the Diabetes Module re-
flects the substantial medical and techno-
logical advances in diabetes care that have
occurred during the past 2 decades (3).
For clinicians who routinely administer
the PedsQL to track patient QOL and
clinical trials researchers who evaluate
the effect of treatment on QOL, it is
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important to establish the amount of
change in PedsQL scores that youth
with diabetes and their parents perceive
as meaningful.
Clinically meaningful change in QOL
occurs when an individual with a chronic
condition perceives an improvement or
worsening in his or her subjective well-
being. The minimal clinically important
difference (MCID) of a QOL measure is a
numerical value indicating the smallest
clinically meaningful amount of QOL
change that can be detected (11,12). To
date, no MCIDs have been calculated for
the PedsQL Diabetes Module. MCIDs for
the PedsQL Generic Core have also not
been calculated for youth with diabetes or
their parents (10). Given the complexity of
diabetes management, it is unclear whether
the establishedPedsQLGenericCoreMCID
scores from other disease populations (13)
can be applied to youth with diabetes.
The primary aim of this study was to
calculate diabetes-specific MCIDs for the
PedsQL parent- and youth-reports on the
Generic Core andDiabetesModule for type
1 and type 2 diabetes. A secondary aimwas
to assess demographic and clinical corre-
lates and predictors of change in QOL
meeting the MCID threshold during a 12-
month follow-up period for participants
with longitudinal data.
RESEARCH DESIGN AND
METHODSdSEARCH for Diabetes in
Youth (SEARCH) is a multicenter observa-
tional study of youth diagnosed with di-
abetes before age 20 years. Participants
were recruited from four geographically
defined populations in Ohio, Washington,
South Carolina, and Colorado, health plan
enrollees in Hawaii and California, and
Indian Health Service beneficiaries from
four American Indian populations. All
registered patients were invited by mail,
telephone, or at a clinic visit to complete
a brief initial survey, and all survey com-
pleters whose diabetes was not secondary
to other conditions were invited by tele-
phone or at a clinic visit to complete a
baseline research visit.
Participants whose diabetes was inci-
dent in 2002–2005 who completed the
baseline study visit were invited for follow-
up visits at 12, 24, and 60 months after
their baseline study visit. During these vis-
its, participants provided informed consent
or, for those younger than 18 years old,
assent and completed questionnaires. For
metabolically stable participants (i.e., no
episode of diabetic ketoacidosis during
the previousmonth), fasting blood samples
were drawn after aminimum8-h overnight
fast. The study was approved by the insti-
tutional review board(s) at each study site.
These analyses include data from base-
line visits of the 2001 (prevalent) cohort and
from the baseline and 12-month follow-up
visits of the 2002–2005 (incident) cohorts.
Baseline visits were completed by 45.7% of
the eligible cohort (5,294 visits/11,592
subjects). After excluding 290 participants
(5.5%) without at least one PedsQL mod-
ule completed by youth or parent, the final
baseline sample included 5,004 partici-
pants (2,462 prevalent and 2,542 incident
subjects). These data were used to calculate
MCIDs. Of the 2002–2005 incident co-
horts who completed the baseline and 12-
month follow-up visits (n = 1,449, 57% of
incident sample with baseline visits), 47
(3.2%) without at least one PedsQL mod-
ule were also excluded, resulting in a final
sample of 1,402 participants to identify
predictors of QOL change over time.
Youth and their parents reported on
youths’ generic and health-relatedQOL us-
ing the PedsQL Generic Core and Diabetes
Module (3). All youth aged 5 years and
older completed an age-appropriate self-
report version of the two PedsQL mod-
ules. Items were read to the child or given
to the child to read, depending on the
child’s reading skills. In addition, parents
completed a parent-proxy version of the
measures for all youth aged younger than
18 years at the time of their visit. Thus,
participants aged 18 years and older had
one score for each module (self-report),
participants aged between 5 and 17 years
received two scores for eachmodule (youth
and parent report), and participants aged
younger than 5 years had one score for
each module (parent report only). Scores
reported by youth and parents on each
module were analyzed separately.
For all versions, items assess the degree
of difficulty youth experiencewith different
aspects of everyday living, including phys-
ical symptoms and emotional, social, and
academic functioning (Generic Core), as
well as treatment adherence and barriers,
diabetes-related worries, and communica-
tion with others about diabetes (Diabetes
Module). Item scoreswere transformed,with
subscale and total scale scores ranging from
0 to 100. Higher scores reflect better QOL.
The PedsQL Generic Core and Diabetes
Module are psychometrically sound (3).
Demographic and medical informa-
tion was collected by self-report or parent
report and medical record review. Partic-
ipants’ self-reported race and ethnicity
were collected using standard census
questions. Those who self-reported being
of Hispanic ethnicity were categorized as
Hispanic, regardless of race, and the re-
mainder were categorized by self-reported
race. If no or multiple races were endorsed,
participants were categorized as “other/
unknown race/ethnicity.” Health insur-
ance was categorized as private, state/fed-
erally funded, other (including Indian
Health Service, student health clinics, mil-
itary, or other/unknown sources), or none
based on self-report.
Clinical data, including physical mea-
surement and fasting blood samples, were
obtained at the baseline SEARCH study
visit. Glycemic control was assessed via
glycated hemoglobin (A1C) using high-
performance liquid chromatography (Tosoh
Bioscience, Montgomeryville, PA). BMI
was calculated from height and weight
measured at the initial study visit, and
z-scores (zBMI) were calculated using
Centers for Disease Control and Preven-
tion algorithms (14,15). Diabetes type was
determined by physician diagnosis, and
comorbid medical diagnoses were based
on self-report or parent report.
Data analysis
Themean (SD) and scale reliability (Cron-
bach a) values were calculated for each
subscale and the total scores for the Ge-
neric Core and the Diabetes Module.
MCIDs were calculated using a com-
monly used distribution-based method:
one standard error of measurement
(SEM) (12,16). The following equation
is used to calculate the SEM: SEM = SD!
[12 a], where a is the total score or sub-
scale reliability estimate. The SEM esti-
mates the variation in scores due to the
measurement precision in the scale and
assumes that a change in scores smaller
than the value of the SEM likely results
from measurement error rather than a
meaningful increase or decrease in the
value of the construct being measured
(in this case, QOL). A score change
greater than or equal to the value of the
SEM represents meaningful variation in
the measured construct that is likely not
due to measurement error. MCIDs for
various QOL (17,18) measures, including
theMCID for the PedsQL across a range of
pediatric chronic conditions (13), have
been calculated using this approach.
This statistical methodology produces
MCIDs that are expressed in the same
units of measurement as the QOL score
(19). The SEM and resulting MCIDs were
calculated for the sample of participants
and parents for the total and subscale
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scores of the Generic Core and Diabetes
Module and were also established sepa-
rately for each diabetes type. The result
is a single value that represents the magni-
tude of change in scores on QOLmeasures
that is detectable to the individual with the
chronic condition. Thus, the MCID
represents a clinically meaningful or im-
portant difference in QOL that can be ref-
erenced in clinical practice and research.
To examine predictors of change in
QOL, two sets of regression analyses were
conducted using data from the subset of
participants diagnosed from 2002–2005
with a 12-month follow-up visit and com-
plete data at both time points (total N =
1,402 [n range 1,072–1,094] across the
two modules and two reporters). General
linear regression models were construc-
ted to determine the demographic and
clinical characteristics that predicted the
amount and direction of improvement or
worsening in PedsQL change scores.
PedsQL change scores were calculated as
total score at the follow-up visit minus
total score at the baseline visit. Predictors
were demographic and clinical variables
that have previously demonstrated asso-
ciations with QOL, including age, sex, in-
surance coverage, race/ethnicity, diabetes
type, diabetes duration, z-BMI, and A1C,
all of which were assessed at the baseline
visit, and models controlled for PedsQL
scores at baseline.
Next, to determine the characteristics
that predicted clinically meaningful im-
provement in QOL, participants’ PedsQL
change scores for 1 year were categorized
as positive (score increase$1 MCID), neg-
ative (score decrease $1 MCID), or no
change. Binary logistic regression models
were constructed to predict positive QOL
change of at least 1 MCID compared with
negative/no QOL change, controlling for
all measured demographic and medical
variables noted above, time from baseline
to follow-up, and baseline PedsQL scores.
Separate analyses were conducted for par-
ent and child report of the Generic Core
and Diabetes Module total scores.
RESULTS
Characteristics of participants
The study sample was composed of 5,004
children, adolescents, and young adults
diagnosed with type 1 or type 2 diabetes
in 2002 through 2005 (n = 4,393) or
whose diabetes was prevalent in 2001
(n = 611). Youth were a mean age of
12.5 years (SD, 4.7; range, 2–22 years),
51.3% female, 67.9% non-Hispanic
white, and 19.3% were publically insured
(Medicaid/Medicare). The demographic
and clinical characteristics of participants
in the study sample stratified by diabetes
type are reported in Table 1.
The internal consistency of the PedsQL
total scores for the sample was excellent for
the Generic Core (youth report: a = 0.87,
parent report:a = 0.88) andDiabetesMod-
ule (youth report: a = 0.85, parent report:
a = 0.88). Subscale a values were more
variable (Table 2). Inmost cases, the youth-
and parent-reported total and subscale
scores were consistently higher for type 1
diabetes than for type 2 diabetes, although
the SDs were quite large for both groups.
MCIDs
The PedsQL was completed by 4,041
participant–parent pairs for participants
aged between 5 and 17 years, 551 partici-
pants aged18yearsor older, and412parents
of participants aged younger than 5 years.
TheMCID for the Generic Core total score
was 4.83 for youth-report and 5.16 for
parent-report (Table 2). For youth with
type 1 diabetes, the Generic Core MCIDs
were 4.72 for youth-report and 4.88 for
parent-report. The Generic Core MCIDs
were higher for those with type 2 diabetes
compared the MCIDs for youth with type
1 diabetes; MCIDs among youth with type
2 diabetes were 5.41 for youth-report and
6.27 for parent-report. The MCID for the
Diabetes Module total score was 5.34 for
youth-report and 4.64 for parent-report.
The Diabetes Module MCIDs for partici-
pants with type 1 diabetes were 5.27 for
youth-report and 4.54 for parent-report.
As with the Generic Core MCIDs, the Di-
abetes Module MCIDs were higher
among youth with type 2 diabetes: 5.96
for youth-report and 6.06 for parent-
report. Subscale MCIDs for the Generic
Core and Diabetes Module are presented
in Table 2.
Predictors of change in QOL scores
during 1 year
Longitudinal analyseswere conductedwith
data from 1,402 youth with at least one
parent- or youth-reported score on the
Generic Core or Diabetes Module at the
12-month follow-up visit (n range 1,072–
1,984 across the two modules and two re-
porters; Table 3). This subset comprises
55% of the 2002–2005 incident cohorts
that were included in the baseline visit sam-
ple for this study. The 12-month follow-up
visits occurred on average 14.6months (SD
Table 1dBaseline demographic and clinical characteristics of 5,004 study participants,
by diabetes type: SEARCH for Diabetes in Youth Study, 2001–2005
Total sample Type 1 Type 2
Sample size
Youth report, n 4,582 4,000 548
Parent report, n 4,444 3,988 430
Age (years) 12.5 6 4.7 12.1 6 4.7 16.2 6 2.8
Sex (% female) 2,565 (51.3) 2,195 (49.7) 349 (62.8)
Race/ethnicity
Non-Hispanic white 3,397 (67.9) 3,272 (74.1) 107 (19.2)
Hispanic 658 (13.2) 521 (11.8) 127 (22.8)
Black/African American 520 (10.4) 333 (7.6) 184 (33.1)
Asian/Pacific Islander 127 (2.5) 78 (1.8) 45 (8.1)
Native American 103 (2.1) 25 (0.6) 78 (14.0)
Other/unknown 199 (4.0) 184 (4.2) 15 (2.7)
Insurance
Private 3,795 (76.3) 3,489 (79.5) 284 (51.5)
State (Medicaid) 962 (19.3) 752 (17.1) 204 (37.0)
Other 125 (2.5) 81 (1.9) 40 (7.3)
None 92 (1.9) 66 (1.5) 23 (4.2)
Diabetes duration (years) 3.4 6 3.7 3.6 6 3.8 2.0 6 1.8
A1C (%) 8.1 6 1.7 8.2 6 1.6 7.9 6 2.5
BMI (kg/m2) 22.4 6 7.0 20.9 6 4.7 34.6 6 9.6
zBMI 0.77 6 1.01 0.62 6 0.92 1.99 6 0.77
Continuous data are expressed as mean6 SD and categorical data as n (%). The samples with type 1 diabetes
and type 2 diabetes do not sum to the total sample because the total sample included 34 participants with
other types of diabetes. The number of participants who completed the youth report exceeds that of those
who completed the parent-proxy report because 636 of the participants were aged$18 years at the time of
their initial visit.
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3.1 [range 6.0–28.1]) after the initial visit.
The youth in the longitudinal analysis were
younger and had shorter disease duration
(due to the exclusion of the participants
whose diabetes was prevalent in 2001),
and lower zBMI (all P , 0.05) than youth
in the larger cross-sectional sample used to
calculate MCIDs at baseline.
In the linear regression models, im-
provements in youth-reported Generic
Core and Diabetes Module PedsQL change
scores during 1 year were predicted by
Table 2dMCIDs for the PedsQL Generic Core and Diabetes Module at the baseline study visit, by reporter (youth/parent) and diabetes type:
SEARCH for Diabetes in Youth Study, 2001–2005
Total sample Type 1 diabetes Type 2 diabetes
Mean 6 SD a MCID Mean 6 SD a MCID Mean 6 SD a MCID
PedsQL Generic Coredyouth-report (n = 4,582)
Total score 79.9 6 13.4 0.87 4.83 80.5 6 13.1 0.87 4.72 75.7 6 15.0 0.87 5.41
Physical 84.8 6 13.8 0.76 6.76 85.4 6 13.4 0.76 6.56 80.6 6 16.1 0.75 8.05
Emotional 74.0 6 19.6 0.72 10.37 74.7 6 19.3 0.72 10.21 69.1 6 21.0 0.74 10.71
Social 85.0 6 17.9 0.80 8.01 85.4 6 17.7 0.81 7.72 82.3 6 19.2 0.78 9.01
School 72.8 6 18.2 0.89 6.04 73.5 6 17.8 0.89 5.90 68.1 6 20.5 0.87 7.39
PedsQL Generic Coredparent-report (n = 4,444)
Total score 77.5 6 14.9 0.88 5.16 78.5 6 14.1 0.88 4.88 68.0 6 18.1 0.88 6.27
Physical 82.9 6 17.6 0.83 7.26 84.3 6 16.3 0.83 6.72 69.8 6 23.0 0.80 10.29
Emotional 69.9 6 18.6 0.77 8.92 70.3 6 18.4 0.77 8.82 66.3 6 20.6 0.77 9.88
Social 82.9 6 18.4 0.77 8.82 84.0 6 17.5 0.79 8.02 72.9 6 23.5 0.69 13.08
School 70.0 6 20.2 0.92 5.71 70.9 6 19.7 0.93 5.21 62.2 6 22.0 0.83 9.07
PedsQL Diabetes Moduledyouth-report (n = 4,571)
Total score 73.8 6 13.8 0.85 5.34 74.2 6 13.6 0.85 5.27 70.7 6 15.4 0.85 5.96
Symptoms 65.7 6 16.7 0.79 7.65 65.6 6 16.5 0.79 7.56 65.5 6 18.3 0.79 8.39
Barriers 78.9 6 18.8 0.65 11.12 79.9 6 18.1 0.64 10.86 71.6 6 21.9 0.68 12.39
Adherence 82.0 6 16.3 0.64 9.78 82.4 6 16.0 0.61 9.99 78.5 6 18.4 0.73 9.56
Worry 73.8 6 23.1 0.71 12.44 74.4 6 22.7 0.72 12.01 69.1 6 25.1 0.66 14.64
Communication 78.3 6 23.2 0.90 7.34 79.0 6 22.7 0.89 7.53 73.2 6 25.7 0.91 7.71
PedsQL Diabetes Moduledparent-report (n = 4,440)
Total score 70.4 6 13.4 0.88 4.64 70.6 6 13.1 0.88 4.54 68.2 6 16.2 0.86 6.06
Symptoms 65.0 6 15.5 0.84 6.20 65.1 6 15.0 0.85 5.81 63.5 6 19.4 0.82 8.23
Barriers 70.1 6 19.7 0.70 10.79 70.4 6 19.3 0.70 10.57 67.8 6 23.6 0.70 12.93
Adherence 76.9 6 16.8 0.67 9.65 77.2 6 16.4 0.66 9.56 73.9 6 19.7 0.71 10.61
Worry 72.5 6 22.2 0.82 9.42 72.4 6 22.0 0.85 8.52 74.0 6 23.6 0.70 12.93
Communication 73.6 6 25.6 0.90 8.10 74.2 6 25.0 0.90 7.91 67.9 6 29.5 0.89 9.78
Table 3dLinear regression analysis of predictors of change in PedsQL total scores* between the baseline and 12-month follow-up visit:










b P value b P value b P value b P value
Age (years) 0.14 0.1621 20.12 0.2295 0.02 0.8851 20.12 0.0253
Sex (female) 21.66 0.0128 21.93 0.0054 20.08 0.9159 20.07 0.9113
Insurance (nonprivate) 22.25 0.0068 22.28 0.0081 22.46 0.0073 21.08 0.1768
Race/ethnicity (non-Caucasian) 20.05 0.9476 20.21 0.8013 0.72 0.4174 0.14 0.8594
Diabetes type (type 1) 20.12 0.9242 21.64 0.2145 4.36 0.0036 0.71 0.5915
Diabetes duration (months) 0.02 0.6585 20.01 0.7630 20.003 0.9537 0.12 0.0039
zBMI 0.10 0.7873 0.04 0.9094 20.26 0.4994 20.35 0.3040
A1C (%) 20.09 0.6728 20.32 0.1766 20.98 0.0002 20.84 0.0004
Baseline score 20.50 ,0.0001 20.52 ,0.0001 20.47 ,0.0001 20.40 ,0.0001
*Mean change in PedsQL total scores was 1.60 and 1.85 for Generic Core and DiabetesModule for youth, respectively, and20.02 and20.40 for the Generic Core and
Diabetes Module for parents, respectively.
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lower baseline QOL (b = 20.50 and b =
20.52, respectively; P , 0.0001), male
sex (b = 21.66 and b = 21.93, respec-
tively; P , 0.05), and being privately
insured (b = 22.25 and b = 22.28, re-
spectively; P, 0.01). For parent-reported
scores, lower baseline QOL (b = 20.47,
P , 0.0001), private insurance (b =
22.46, P , 0.01), diagnosis of type 1 di-
abetes (b = 4.36, P , 0.01), and lower
baseline A1C (b =20.98, P, 0.001) pre-
dicted greater improvements in Generic
Core change scores. Lower baseline QOL
(b = 20.40, P , 0.0001), lower baseline
A1C (b = 20.84, P , 0.001), and longer
duration of diabetes (b = 0.12, P , 0.01)
predicted greater improvement in Diabe-
tes Module change scores.
Across scales, reporters, and diabetes
type, approximately one-third of the sam-
ple had PedsQL change scores that de-
creased by $1 MCID, one-third had no
significant QOL change, and one-third
had change scores that increased by $1
MCID. In the logistic regression models
predicting a clinically meaningful im-
provement ($1MCID) in PedsQL change
scores (Table 4), baseline QOL scores sig-
nificantly predicted an improvement for
both youth- and parent-reports on the
Generic Core and Diabetes Module (OR
range 0.92–0.94, all P , 0.0001). For
youth-report, there were no additional
predictors of clinically meaningful im-
provements on the Generic Core beyond
baseline QOL scores, whereas clinically
meaningful improvements in Diabetes
Module scores were also predicted by
being privately insured (OR 0.68 [95%
CI 0.48–0.98], P , 0.05). For parent-
report, beyond baseline QOL scores, clin-
ically meaningful improvements on the
Generic Core were also predicted by pri-
vate insurance (OR 0.65 [0.45–0.94], P,
0.05), lower BMI (0.86 [0.74–1.00], P ,
0.05), and lower A1C (0.85 [0.77–0.95],
P , 0.01), whereas clinically meaningful
improvements on the Diabetes Module
were also predicted by lower A1C (0.87
[0.79–0.97], P , 0.05).
CONCLUSIONSdThe MCIDs for the
PedsQL Generic Core total score estab-
lished in this study were consistent with
published Generic Core total score
MCIDs in other chronic conditions (4.36
for youth-report and 4.50 for parent-
report) (13), ranging between 4 and 6
points across reporter and diabetes type.
The values for most of the Generic Core
subscales in the current sample of youth
with type 1 and type 2 diabetes were
higher than the PedsQLGeneric Core sub-
scale MCIDs for youth with other chronic
conditions, which are physical health,
6.66, 6.92; emotional functioning, 8.94,
7.79; social functioning, 8.36, 8.98; and
school functioning, 9.12, 9.67, for youth-
and parent-report, respectively (13). The
only exception was the School Function-
ing subscale, which was lower for both
youth- and parent-reports.
The higher MCIDs for most Generic
Core subscales in this sample compared
with other conditions suggests that across
various domains of functioning, youth
with diabetes seem to require more im-
provement or deterioration in QOL to
perceive a clinicallymeaningful difference
in their subjective experience than do
youth with other chronic conditions.
Given the complexity of the diabetes
treatment regimen, a relatively large
amount of change in QOL (5–10 points)
may be needed for youth or their parents
to perceive any meaningful differences in
everyday functioning or activities. This
pattern was especially pronounced in
youth with type 2 diabetes, who had the
highest MCID thresholds for clinically
meaningful QOL change. Youth with
type 2 diabetes report poorer QOL and
encounter multiple physical complaints
and social and emotional difficulties
(9,20). In addition, given the higher
zBMI scores among youth with type 2 di-
abetes compared with type 1 diabetes,
theremay be a cumulative effect of obesity
and type 2 diabetes on some individuals’
QOL (21). As such, greater change in
QOL may be necessary for youth with
type 2 diabetes to perceive an improve-
ment or deterioration in their subjective
well-being.
For the Diabetes Module, the total
score MCIDs were similar to the Generic
Core total score MCIDs. Although there is
no direct point of comparison for the
subscale MCIDs, it is notable that those of
the Diabetes Module are substantially
higher than the subscale MCIDs for the
Generic Core. In particular, the treatment
barriers, treatment adherence, and wor-
ries subscale MCIDs tended to be at or
Table 4dLogistic regression analysis to identify predictors of ‡1 MCID improvement on PedsQL total score between the baseline and
12-month follow-up study visits: SEARCH for Diabetes in Youth Study, 2002–2005 incident cases
Youth-report Parent-report
Generic Core (n = 1,086) Diabetes Module (n = 1,072) Generic Core (n = 1,093) Diabetes Module (n = 1,094)
OR (95% CI) Wald x2 OR (95% CI) Wald x2 OR (95% CI) Wald x2 OR (95% CI) Wald x2
Age (years) 1.01 (0.97–1.05) 76.6 0.97 (0.93–1.01) 2.21 1.00 (0.96–1.04) 0.01 0.99 (0.95–1.03) 0.16
Sex (female) 0.95 (0.71–1.26) 0.11 0.81 (0.61–1.07) 2.22 0.94 (0.70–1.25) 0.19 1.00 (0.76–1.32) 0.00
Insurance
(nonprivate) 0.77 (0.54–1.10) 0.13 0.68* (0.48–0.98) 4.20 0.65* (0.45–0.94) 5.36 0.92 (0.65–1.30) 0.24
Race/ethnicity
(non-Caucasian) 0.98 (0.70–1.39) 0.01 1.03 (0.73–1.46) 0.03 1.24 (0.88–1.76) 1.51 1.06 (0.75–1.49) 0.10
Diabetes type (1) 0.80 (0.46–1.38) 0.66 0.79 (0.46–1.39) 0.66 1.40 (0.77–2.54) 1.22 1.30 (0.73–2.33) 0.77
Diabetes duration
(months) 1.01 (0.99–1.03) 1.05 1.00 (0.98–1.02) 0.00 0.99 (0.97–1.01) 0.44 1.01 (0.99–1.03) 0.59
zBMI 0.89 (0.76–1.04) 2.31 0.98 (0.85–1.14) 0.05 0.86* (0.74–1.00) 3.85 0.97 (0.84–1.13) 0.16
A1C (%) 0.93 (0.84–1.02) 2.37 0.97 (0.88–1.07) 0.44 0.85** (0.77–0.95) 8.65 0.87* (0.79–0.97) 6.49
Time to follow-up 1.01 (0.96–1.05) 0.07 0.99 (0.94–1.04) 0.25 1.03 (0.99–1.08) 2.05 0.99 (0.94–1.03) 0.35
Baseline score 0.92† (0.91–0.93) 172.48 0.92† (0.91–0.93) 170.65 0.93† (0.92–0.94) 145.63 0.94† (0.93–0.95 108.86
Reference group is shown in parenthesis. *P , 0.05, **P , 0.01, †P , 0.0001.
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above 10 points. The higher MCIDs
for these subscales reflect their lower
Cronbach’s a values. Although these sub-
scales have not been supported by factor
analyses conducted on responses from
youth with type 1 diabetes (7,10), sub-
scale MCIDs are reported here for com-
parison purposes and to illustrate mean
score and a similarities between parents
of youth with type 1 and type 2 diabetes,
which had not previously been reported
by the SEARCH study.
For clinicians and clinical trials re-
searchers, fluctuations inQOL that do not
meet the MCID threshold may not be
noticeable by patients or their families yet
should be monitored to determine
whether more substantial challenges arise
and require intervention. The relatively
higher MCIDs for youth with diabetes
than for youth with other chronic con-
ditions may translate to a need for inter-
ventions that explicitly target various
components of general and diabetes-
specific QOL to achieve a change of
sufficient magnitude for patient and par-
ent perception of improvement. Interven-
tions to improve QOL may benefit from a
direct, targeted focus on barriers and
facilitators of diabetes management and
control. For example, given previous ev-
idence of strong associations between
lower QOL and more depressive symp-
toms (10), QOL interventions that address
diabetes-specific emotional concerns may
be particularly beneficial. These data sup-
port published and ongoing intervention
studies that demonstrate benefits of pro-
viding psychological support and skills
training to youth with diabetes (12,23).
In addition, efforts to improve QOL
among youth with type 2 diabetes may
achieve greater QOL change by addressing
diabetes and also weight-related domains
of everyday functioning. Associations be-
tween PedsQL scores and A1C suggest that
interventions that address and improve
QOL may ultimately translate to clinical
improvements in glycemic control. One
hypothesis is that patients who perceive
better QOL may encounter fewer barriers
to diabetes management and may be more
motivated to adhere to diabetes treatment
recommendations such as self-monitoring.
Adaptation of established psychological
interventions for youthwith type 1diabetes
to meet the unique needs of youth with
type 2 diabetes is needed (23).
Longitudinal findings demonstrate
that a number of demographic and clin-
ical variables predicted increases in
PedsQL change scores over 1 year. The
association between lower PedsQL scores
at baseline and larger change scores at 12
months likely reflects that participants
with poorer initial QOL had more oppor-
tunity for improvement. The associations
of sex, insurance coverage, diabetes type,
diabetes duration, and A1C at baseline
with 12-month QOL improvements are
consistent with previous studies examin-
ing changes in QOL after clinical or
medical intervention (24,25) and help to
identify patients who may experience
QOL fluctuations over time. Given dif-
ferent predictors of parent- and youth-
reported QOL change, interventions will
need to be tailored to individuals’ unique
experiences to influence each of their per-
ceptions of QOL. Because parent-reported
change scores were predicted by BMI
and A1C, efforts to improve physical
well-being and glycemic control may be
particularly influential on parental percep-
tions of their children’s QOL. However,
the finding that children’s QOL change
scores were predicted by sex and insur-
ance status suggests that girls and those
with public insurance may be most likely
to benefit from additional QOL monitor-
ing. Through this monitoring, it will be
necessary to engage youth in discussion
to identify and address the factors that
are affecting their QOL ratings.
The identification of PedsQL MCIDs
also allowed us to determine the charac-
teristics that predict who is most likely to
experience clinically meaningful im-
provements in QOL. Private insurance
coverage, lower BMI, and lower A1C at
the baseline study visit predicted change
that exceeded the threshold of perceived
improvement in various QOL domains.
Beyond the auto-correlational effects of
baseline QOL, these variables may repre-
sent protective factors, such as greater
access to resources or better health status,
that help individuals rebound from peri-
ods of lower QOL and avoid long-lasting
problems that may ultimately affect di-
abetes management and control.
The interpretation of this study ’s
findings should consider the response
rates and limitations of the PedsQL mod-
ules and their analyses. As previously re-
ported, the baseline visit response rate
was lower than expected; older youth,
African American youth, and those with
type 2 diabetes were less likely to
complete a visit (26). The PedsQL Diabe-
tes Module was not developed or normed
for youth with type 2 diabetes (3), so the
results of the PedsQLDiabetes Module for
youth with type 2 diabetes and their
parents may have limited utility. Con-
cerns about psychometric properties of
the Diabetes Module subscales among
youth with type 1 diabetes have been re-
ported (7,10) suggesting that use of total
scores, and the associatedMCIDs, is more
appropriate than subscale scores. In addi-
tion, MCIDs were calculated for all
PedsQL subscales for consistency, but
the lower a values for some of these sub-
scales resulted in larger MCIDs, which
should be used with caution. Finally, al-
though we used the same approach to cal-
culate MCIDs as used with the Generic
Core for youth with other chronic condi-
tions (13,18,19) and evidence demon-
strates similarities between MCIDs
established using statistical methods
(e.g., 1 SEM) and those calculated in other
ways (17), alternative MCID calculations
might have yielded different results. Be-
cause concurrent measures of QOL were
not collected, alternative MCID calcula-
tions could not be conducted.
Nonetheless, the establishment of
diabetes-specific MCIDs for the PedsQL
Generic Core and Diabetes Module for
parents and youth provide an important
reference point for clinicians and re-
searchers interested in the effect of treat-
ments on patient QOL. Clinical trials
researchers may use these MCIDs to
evaluate the degree to which an interven-
tion improves participants’QOL in a clin-
ically significant way. Longitudinal
research is needed to determine whether
clinically meaningful changes in per-
ceived QOL are associated with clinically
meaningful changes in indices of diabetes
health status, such as glycemic control
and risk for acute complications.
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